Avadel Pharmaceuticals (AVDL)
(Delayed Data from NSDQ)
$11.15 USD
-0.11 (-0.98%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $11.15 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth C Momentum C VGM
Fundamental Charts
About Dividend Yield (TTM)
Avadel Pharmaceuticals PLC.'s dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
AVDL 11.15 -0.11(-0.98%)
Will AVDL be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for AVDL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AVDL
Wall Street Analysts See an 81.61% Upside in Avadel (AVDL): Can the Stock Really Move This High?
Surging Earnings Estimates Signal Upside for Avadel (AVDL) Stock
AVDL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Analysts Think Avadel (AVDL) Could Surge 97.68%: Read This Before Placing a Bet
All You Need to Know About Avadel (AVDL) Rating Upgrade to Buy
Earnings Estimates Moving Higher for Avadel (AVDL): Time to Buy?
Other News for AVDL
Avadel Pharmaceuticals to Provide a Corporate Update and Report Second Quarter 2025 Financial ...
Avadel Pharmaceuticals PLC (AVDL) Announces Upcoming Conference Call for Q2 2025 Financial ...
Avadel Pharmaceuticals PLC (AVDL) Shares Up 3.92% on Jul 21
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) | AVDL Stock News
AVDL: HC Wainwright & Co. Announces Buy Rating with $22 Price Target | AVDL Stock News